Predicting chemotherapeutic drug combinations through gene network profiling
about
Drug combinatorics and side effect estimation on the signed human drug-target network.Cellular factories for coenzyme Q10 production.Regulation of transcriptional silencing and chromodomain protein localization at centromeric heterochromatin by histone H3 tyrosine 41 phosphorylation in fission yeast.Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems.Histone H3 lysine 36 methyltransferase mobilizes NER factors to regulate tolerance against alkylation damage in fission yeast.Crystal structure and functional analysis of human C1ORF123
P2860
Predicting chemotherapeutic drug combinations through gene network profiling
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Predicting chemotherapeutic drug combinations through gene network profiling
@ast
Predicting chemotherapeutic drug combinations through gene network profiling
@en
type
label
Predicting chemotherapeutic drug combinations through gene network profiling
@ast
Predicting chemotherapeutic drug combinations through gene network profiling
@en
prefLabel
Predicting chemotherapeutic drug combinations through gene network profiling
@ast
Predicting chemotherapeutic drug combinations through gene network profiling
@en
P2093
P2860
P356
P1433
P1476
Predicting chemotherapeutic drug combinations through gene network profiling
@en
P2093
Audrey Yuen
Brian Dymock
Edmund Jon Deoon Lee
Ee Sin Chen
Eugene Guorong Yang
Jacqueline Kia Kee Chua
Jie Yin Yee
Kim Kiat Lim
Kwi Shan Seah
Louxin Zhang
P2860
P2888
P356
10.1038/SREP18658
P407
P50
P577
2016-01-21T00:00:00Z